T-CELL CLONES SPECIFIC FOR P21 RAS-DERIVED PEPTIDES - CHARACTERIZATION OF THEIR FINE SPECIFICITY AND HLA RESTRICTION

被引:58
作者
GEDDEDAHL, T
FOSSUM, B
ERIKSEN, JA
THORSBY, E
GAUDERNACK, G
机构
[1] NATL HOSP,INST TRANSPLANTAT IMMUNOL,N-0027 OSLO,NORWAY
[2] UNIV OSLO,OSLO 3,NORWAY
[3] NORSK HYDRO AS,PORSGRUNN,NORWAY
关键词
ONCOGENE; HLA; RAS-DERIVED PEPTIDES; T-CELLS;
D O I
10.1002/eji.1830230328
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peptides corresponding to the mutated regions of the oncoprotein p21 ras are immunogenic and capable of eliciting HLA class II-restricted T cell responses. Here we report studies on the fine specificity of four T lymphocyte clones (TLC) from a single donor, using various truncated peptides derived from the residues 6-19 of p21 ras and a panel of well-characterized HLA homozygous cells as antigen-presenting cells. Putative minimum peptides of nine or ten amino acids could be defined for each TLC. Two of the TLC recognized peptides presented by DR2, and the two others recognized peptides presented by DQ6. Some notable differences in the requirement for certain amino acids were seen between the DR- and DQ-restricted TLC. Thus, Ser at residue 17 was required for stimulation of the DQ6-but not the DR2-restricted TLC. Val at residue 8 was essential for stimulation of all TLC, whereas one of the DR2-restricted TLC also required Val at residue 7. Some peptides which were nonstimulatory were still capable of binding to DQ6 molecules in peptide competition experiments. The results may be of importance for potential immunotherapy of cancer where transforming ras oncoproteins are involved.
引用
收藏
页码:754 / 760
页数:7
相关论文
共 30 条
[1]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[2]  
BARBACID M, 1988, IMMUNOLOGY SERIES, V41, P121
[3]   PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS [J].
BOS, JL ;
FEARON, ER ;
HAMILTON, SR ;
VERLAANDEVRIES, M ;
VANBOOM, JH ;
VANDEREB, AJ ;
VOGELSTEIN, B .
NATURE, 1987, 327 (6120) :293-297
[4]  
BOS JL, 1989, CANCER RES, V49, P4682
[5]  
CARRENO BM, 1992, J IMMUNOL, V148, P894
[6]  
CELIS E, 1988, J IMMUNOL, V141, P2721
[7]  
CHILDERSTONE A, 1991, J IMMUNOL, V146, P1463
[8]   EPITOPES RECOGNIZED BY HUMAN T-CELLS MAP WITHIN THE CONSERVED PART OF THE GP190 OF P-FALCIPARUM [J].
CRISANTI, A ;
MULLER, HM ;
HILBICH, C ;
SINIGAGLIA, F ;
MATILE, H ;
MCKAY, M ;
SCAIFE, J ;
BEYREUTHER, K ;
BUJARD, H .
SCIENCE, 1988, 240 (4857) :1324-1326
[9]   AUTOANTIGEN RECOGNITION BY THYROID-INFILTRATING T-CELLS IN GRAVES-DISEASE [J].
DAYAN, CM ;
LONDEI, M ;
CORCORAN, AE ;
GRUBECKLOEBENSTEIN, B ;
JAMES, RFL ;
RAPOPORT, B ;
FELDMANN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7415-7419
[10]   T-CELL RESPONSES AGAINST PRODUCTS OF ONCOGENES - GENERATION AND CHARACTERIZATION OF HUMAN T-CELL CLONES SPECIFIC FOR P21 RAS-DERIVED SYNTHETIC PEPTIDES [J].
GEDDEDAHL, T ;
ERIKSEN, JA ;
THORSBY, E ;
GAUDERNACK, G .
HUMAN IMMUNOLOGY, 1992, 33 (04) :266-274